Morning administration of CDK4/6 inhibitor clinical trials

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

This study looks at whether taking cancer medicines in the morning or evening makes a difference for people with advanced breast or prostate cancer. It also checks if the study plan works well for a bigger future trial.